Teva Pharmaceutical Industries announced the launch of an authorized generic of a Type 2 diabetes drug.
Ranbaxy Labs has launched an authorized generic version of a diabetes drug made by Takeda Pharmaceutical, Ranbaxy said Friday.
Global sales of nicotine replacement products are expected to reach $6.2 billion in 2018, following compound annual growth rates of 4.5% between now and then, GBI Research reported Wednesday.
Children who take a class of opioid pain relievers after certain surgeries may be at risk of death, the Food and Drug Administration warned Wednesday.
A division of Teva Pharmaceutical Industries has launched a generic chemotherapy drug, the company said.
Watson Pharmaceuticals is suing the Food and Drug Administration, alleging that an agency decision would improperly delay its release of a generic drug for diabetes, the company said Wednesday.
The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.
Consolidated sales for generic drug maker Ranbaxy Labs totaled $588 million in the second quarter ended June 30, a 28% rise over the year-ago period, the company said.
Sun Pharmaceutical Industries will take Taro Pharmaceutical Industries private, under a merger agreement between the two companies announced Sunday.
Mylan has launched a generic drug used to treat sleep disorders, the company said Friday.